-Amyloid (A ) related pathology shows a range of lesions which diVer both qualitatively and quantitatively. Pathologists, to date, mainly focused on the assessment of both of these aspects but attempts to correlate the Wndings with clinical phenotypes are not convincing. It has been recently proposed in the same way as and synuclein related lesions, also A related pathology may follow a temporal evolution, i.e. distinct phases, characterized by a step-wise involvement of diVerent brain-regions. Twentysix independent observers reached an 81% absolute agreement while assessing the phase of A , i.e. phase 1 = deposition of A exclusively in neocortex, phase 2 = additionally in allocortex, phase 3 = additionally in diencephalon, phase 4 = additionally in brainstem, and phase 5 = additionally in cerebellum. These high agreement rates were reached when at least six brain regions were evaluated. Likewise, a high agreement (93%) was reached while assessing the absence/presence of cerebral amyloid
angiopathy (CAA) and the type of CAA (74%) while examining the six brain regions. Of note, most of observers failed to detect capillary CAA when it was only mild and focal and thus instead of type 1, type 2 CAA was diagnosed. In conclusion, a reliable assessment of A phase and presence/absence of CAA was achieved by a total of 26 observers who examined a standardized set of blocks taken from only six anatomical regions, applying commercially available reagents and by assessing them as instructed. Thus, one may consider rating of A -phases as a diagnostic tool while analyzing subjects with suspected Alzheimer's disease (AD). Because most of these blocks are currently routinely sampled by the majority of laboratories, assessment of the A phase in AD is feasible even in large scale retrospective studies.
Introduction
In 1984, Glenner and Wong puriWed and characterized a novel amyloid protein and in the same year they reported that patients with both Alzheimer's disease (AD) and Down's syndrome display this unique cerebrovascular amyloid Wbril protein that has been called -amyloid (A ) protein [11, 12] . Later it became evident that the native precursor of this A protein was a membrane associated protein [27] . Subsequently, numerous studies have examined postmortem brains and evaluated the A seen in the parenchyma or vessel walls. Most often postmortem brain material obtained from aged or demented subjects suVering from clinically presumed AD has been investigated by applying immunohistochemical (IHC) methodology.
It has generally been considered suYcient to verify the existence of A -immunoreactive (IR) aggregates in the parenchyma in only one or at the most few brain regions. When evaluating the severity of A deposition in relation to clinical symptoms or the inXuence of various risk factors on the propensity towards A -IR aggregation investigators have assessed the type of A aggregates, i.e. diVuse versus dense, the number of aggregates or the extent of deposits by means of morphometry [3, 4, 17, 19] . One common Wnding in aged subjects is the presence of A deposition in vessel walls, i.e. cerebral amyloid angiopathy (CAA) [25] and this is also generally assessed during a neuropathological examination, particularly in subjects with haemorrhages [31] . In 2002, CAA was divided into two types: type 1-CAA is observed in capillaries with or without CAA in arteries and veins and type 2-CAA is detected in arteries and veins [28] . Interestingly, it has been claimed recently that in particular capillary CAA (type 1), is of signiWcance for cognitive impairment probably by causing alterations in the cerebral blood Xow as seen in mouse models for CAA and AD [7, 14, 30] .
The assessment of A in the parenchyma and in the vessel walls has thus become a part of the routine procedure while handling brains obtained from aged and particularly demented subjects. In 2008, a large inter-laboratory study reported that the agreement was poor while assessing the type (diVuse vs. dense) or the number of IHC detectable A aggregates and the type of CAA, but instead good results could be achieved by applying a dichotomized strategy, i.e. assessment of the presence or absence of A -IR deposits or CAA [6] . The most disturbing factor was that the above results were not signiWcantly altered even when the same antibody provided good IHC staining [6] . The conclusion was that a more reliable and reproducible method is needed for the assessment of the severity of A deposition and the type of CAA in inter-laboratory setting.
In 2002, Thal and colleagues reported that while analyzing 51 postmortem brains, a distinct pattern of involvement of brain regions with A aggregates could be observed [29] . The regional involvement was divided into Wve phases, i.e. deposition of A detected exclusively in neocortex was called phase 1, if additionally in allocortex it was phase 2, if also in diencephalon and striatum it was phase 3, if also in brainstem it was phase 4 and Wnally if also in cerebellum it was termed as phase 5. This stepwise involvement was considered to be typical for AD [29] .
It was considered that in comparison to the assessment of the type or the density of A -IR lesions, this kind of dichotomized analysis of A -IR in various regions might yield reproducible results even in an inter-laboratory setting [6] . Furthermore, assessment of the regional distribution might be even more signiWcant than previously appreciated. Recent studies have indicated that in subjects with the presenilin-1 mutation the A deposition begins in striatum, i.e. it does not follow the above progression [16, 18] . In other studies, A aggregates have been observed Wrst in deep grey matter structures in dementia with Lewy bodies [2, 13, 24] , Parkinson disease with dementia [15] and in subjects with stroke [1] . Thus, the assessment of the distribution of A aggregates in a subject with AD related tauopathy might be more than relevant since any alteration from the expected pattern may reXect a genetic alteration or the existence of a signiWcant concomitant disease process.
The objective of this study was to quantify inter-rater agreement of 26 neuropathologists who were asked to rate A deposits in 34 cases by applying the strategy described by Thal and colleagues [29] . The agreement among observers while assessing CAA and in particular the type of CAA was also examined. A second objective was to identify any pitfalls that might have an impact on the agreement rates.
Materials and methods
The general working schedule is summarized in Fig. 1 .
Sampling of material
Thirty-four cases were included and sampling of blocks was carried out by one neuropathologist (IA). Ten anatomical regions were included in this study: 1-cerebellar hemisphere, 2-midbrain with substantia nigra and central grey, 3-striatum (caudate nucleus and putamen) and insular cortex, 4-basal forebrain (with nucleus basalis of Meynert), amygdala and hypothalamus, 5-cingulated gyrus, 6-hippocampus at the level of lateral geniculate nucleus with CA regions, remnants of ento rhinal cortex and temporo-occipital cortex, 7-occipital cortex, visual cortex including calcarine Wssure, 8-temporal cortex, superior and middle temporal gyrus, 9-parietal cortex, Brodmann area 39/40 and 10-frontal cortex, Brodmann area 9. In all of the examined cases A -IR deposits were detected.
A total of Wve sets of 7 m-thick sections were produced from all ten brain areas of the 34 cases. The description of these cases is provided in Table 1 . (Table 3 ) Agreement between participating neuropathologists/ observers and the reference group when assessing β-amyloid immunolabelled lesions while following the recommended published strategy (Table 5) The minimum of regions required for assignment of the β-amyloid phase (Table 6) Absence/presence of cerebral amyloid angiopathy (CAA) and type 1 CAA in relation to the selection of assessed regions ( Table 7 ).
Staging of selected cases
All sections stained by applying antibodies against β-amyloid were re-assessed jointly under multi-headed microscope. Each case was assigned a Aβ phase and the presences of cerebral amyloid angiopathy (CAA) and capillary CAA were noted.
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Design of instructions
Detailed instructions in text, table and figure format were designed and an assessment sheet was constructed (Tables 2, 3, 4 
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Joint assessment During a consensus meeting held around a multi-headed microscope, all 34 cases were examined and discussed. Pitfalls were identified.
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The co-ordinating centre
Summary of results
All detailed results were filed and analyzed. Results which would be obtained when the number of blocks was reduced were calculated.
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Sampling of the material Inclusion of blocks (Table 2 ) was based on the recommendations given in the original article . Material included 34 cases with β-amyloid deposits (Table 1) Immunohistochemistry Five sets of the ten sampled sections were manually stained by applying IHC methodology. In brief, after rehydration, one set was pre-treated with 80% formic acid for 6 h and four sets for 1 h. All Wve sets were subsequently incubated overnight at 4°C with a monoclonal primary antibody directed against A . The Wrst set with an antibody from Dako, clone 6F/3D, dilution 1:100 (Box 1) and four sets with an antibody from Signet, clone 4G8, dilution 1:2000 (Box 2-5). The reaction product was visualized using the Power vision detection system (ImmunoVision Technologies Co., MA, USA) with the use of Biosource Romulin AEC as the chromogen (Biocare medical, Walnut Creek, CA, USA).
The members of the reference group (IA, DRT, TA, ND, HK) jointly re-assessed all cases around a multi-headed microscope. The reference group assigned each case a phase of A deposition and stated whether or not CAA and capillary CAA could be seen (Table 1 ) [28, 29] . Furthermore, the results obtained with the two diVerent antibodies were compared. Detailed assessment instructions were written by the reference group. The instructions included a description of the samples, pictures of the pathology that was present and expected to be assessed (Figs. 2, 3, 4) , general instructions regarding assessment (Table 2 ) and tabulated guidelines (Table 3 ) on how to designate an A phase. Furthermore, each participant was urged to read the original publications on which the assessment procedure was based [28, 29] .
BNE participant eVorts
Twenty-six participants assessed each case as instructed, thus each box of Wve produced sets was assessed by Wve to six examiners. The results were recorded on sheets (Table 4) which were sent to the coordinating centre. At the coordination centre, all data found in the assessment sheets was collected into one Wle (MP). These sheets included information on whether or not the participant had identiWed the required neuroanatomical regions, whether or not A -IR, A -IR plaques, CAA and capillary CAA had been observed and the designated A phase and CAA type of the case. In addition, each participant stated whether or not the distribution of the pathology seemed to progress as expected, i.e. whether it was a typical or an atypical case.
Consensus meeting and joint assessment
A joint assessment of all IHC labelled sections was carried out around a multi-headed microscope. The diagnostic features of each stage were discussed. While studying the stained sections under the multi-headed microscope, the actual observations were compared with the Wled results that had been collected from the original sheets. Inconsistencies in these observations were discussed and pitfalls were identiWed.
Analysis of the obtained data
At the coordinating centre, the data found in the assessment sheet was re-evaluated. With respect to CAA the results were calculated if only one or some of the sections had been included. Likewise, the inXuence of a reduction in the number of brain regions provided on the designation of the A phase was analyzed. These calculations were carried out in order to determine the minimum number of neuroanatomical regions required to be assessed in order to achieve the desired result. Digital images were taken using a Leica DM4000 B microscope equipped with a Leica DFC 320 digital camera.
Results
The results when 26 neuropathologists/observers assessed the IHC stained sections of the 34 cases by adhering to the given instructions are summarized in Tables 5 and 6 .
The assigned phase while assessing the sections applying clone 6F3D did not diVer from the results obtained with clone 4G8. There was only one case in phase 2 (case 4) and this case was unfortunately not optimal. According to the reference group, case four (Table 1) fulWlled phase 2 criteria in one stained set while applying clone 4G8 (absolute agreement 67%) whereas in the remaining 4 sets, the pathology was seen regionally to such an extent that only phase 1 criteria were fulWlled (absolute agreement 76%). Thus the only phase 2 case has been omitted from Table 5 .
A -IR pathology was seen by most raters in all cases. In one case which had been designated as phase 1 by the reference group, two assessors failed to detect any A -IR pathology. The overall agreement while assigning the phase of A deposition in 34 cases was 81% (when case 4 was excluded the value rose to 84%) while assessing all of the ten neuroanatomical regions ( Table 5 ). Most of the cases were considered as being typical, i.e. at least one of the regions required for designation of that phase was aVected.
Most of the evaluators participated in the consensus meeting where a joint assessment of the stained sections under a multi-headed microscope and the previous results obtained from the assessors were scrutinized. The group as a whole concluded that all cases were indeed in the phase designated by the reference group.
When assessing the individual results, it was noted that only some of the neuroanatomical regions were required in State for each sample whether or not (yes/no) the region to be assessed (Table 4) is identiWed Note that you should only assess the regions requested and disregard lesions in any other region in a section. In midbrain assess substantia nigra and periventricular grey and disregard lesions in any other area e.g., in the superior and/or inferior colliculus. In the basal forebrain block assess amygdaloid nucleus, nucleus basalis of Meynert and hypothalamus, but not globus pallidus etc.
Always ignore cellular A -IR e.g. neuronal or glial cytoplasm and diVuse cytoplasmic labelling of muscle cells (Fig. 2) State for each assessable and identiWed region whether or not (yes/no) A -IR aggregates are seen. A aggregates refers to both various parenchymal A aggregates (Xeecy, diVuse, lake like, dense etc.) (Fig. 3) and A deposits in blood vessels (cerebral amyloid angiopathy), i.e. arteries, veins and capillaries (Fig. 4) State for each identiWable regions whether or not (yes/no) A -IR plaques are seen in the neuropil/parenchyma (Fig. 3) State for the selected region whether or not (yes/no) CAA is seen (Fig. 4) State for the selected region whether or not (yes/no) capillary CAA is seen (Fig. 4) Give a A phase following the instructions given in Table 3 . Note, while giving the phase assesses only plaques and ignore CAA Give a type of CAA, i.e. type 2-CAA is seen in arteries and veins, type 1-CAA is seen in capillaries with or without CAA in veins and arteries order to reach a reliable result (Table 6 ). In all three cases in phase 1, frontal, occipital or temporo-occipital cortices were assessed by most observers as being aVected (absolute agreement 84%), in eight cases in phase 3, remnants of ento rhinal cortex (phase 2) and amygdaloid nucleus and nucleus basalis of Meynert (phase 3) were repeatedly aVected (absolute agreement 80%).
The agreement while assessing CAA in all ten included sections was as high as 96% (Table 6 ). Likewise, the agreement was high while assessing leptomeningeal versus parenchymal involvement whereas slightly less harmony was obtained while classifying the type of CAA. There were 16 cases that displayed capillary CAA according to the reference group and this assessment result was veriWed at the joint assessment session around the multi-headed microscope. In six of the cases (cases 9, 11, 21, 27, 28 and 29), most of the 26 assessors had assigned the case as being of type 2, i.e. no capillary involvement was noted. In all of these cases only few aVected capillaries were detected in one or two regions (hippocampus and or occipital cortex). The agreement rates did not change signiWcantly when the number of blocks to be assessed was reduced, though the overall results were signiWcantly diVerent. The overall detection of CAA dropped from 28 to 22 cases, CAA in parenchyma from 24 to 16 cases and the number of cases with type 1 CAA, from 10 to 7 cases ( Table 7) . The results while assessing CAA in three brain In a typical case detected immunoreactivity should be seen as given in the table. A case that skip's any of the regions is marked as atypical. The anatomical regions that are particularly important for a given phase are marked in bold regions, i.e. frontal and occipital cortices and hippocampus [8] or in the six regions selected above were almost the same as those obtained while assessing all ten original blocks.
Discussion
While rating the regional distribution of A -IR, i.e. the phase of A , an 81% agreement was reached when 26
neuropathologists assessed 34 cases all of which displayed A -IR pathology. The agreement increased to 84%, when one case, that in most assessment sets displayed phase 1 and in one set phase 2, was excluded. By following the instructions that were based on the original publication by Thal and colleagues an agreement from 74 up to 90% could be achieved by assessing all ten included brain sections [29] . The lack of a phase 2 case even after a systematic search from a large original sample was unfortunate however; this might indicate that this phase is quite unusual or perhaps even virtually non-existent. Only a systematic assessment of forthcoming cases will resolve this issue. Interestingly, similar agreement rates and assessment results were obtained when the number of blocks was reduced to six. It is noteworthy that these blocks are the same that are commonly sampled while working with brain specimens that have to be evaluated either due to the high age of the deceased or due to an age related neurodegenerative disorder. The hippocampal section and occipital cortex are assessed when dealing with AD-related tauopathy, basal forebrain section is evaluated when dealing with tauopathies and especially when one needs to deal with synucleinopathy, the midbrain section is examined when dealing with synucleinopathy, the section obtained from frontal cortex is assessed when dealing with TAR DNA binding protein (TDP-43) related pathology and Wnally cerebellum is evaluated when there is a suspicion of spinocerebellar ataxias [5, 9, 10, [20] [21] [22] [23] 26] . Thus, these six brain sections are probably sampled in all laboratories during a routine neuropathological evaluation and consequently the proposed assessment of A phase is quite feasible.
The high agreement here was also related to the fact that the assessors only had to evaluate the absence or presence of A -IR pathology and thus the results were not inXuenced by the previously reported variability in the assessment of the extent of the pathology [6] .
The agreement rates with respect to CAA were also high. Almost all, 96% of observers noted vascular involvement in the 28 cases in the same way as originally characterized by the reference group and conWrmed in the joint assessment carried out around a multi-headed microscope. This result was not altered when only six blocks were selected.
The agreement was close to 80% in the classiWcation of the type of CAA, i.e. 76% of assessors had seen capillary involvement in ten of the included cases. It is noteworthy that in six cases, most of the observers had failed to detect capillary CAA and only arterial and/or venous involvement was registered. In all of these cases, only a few capillaries in one or two regions were involved. This result emphasises that mild capillary involvement even after assessing numerous brain regions might easily be overlooked. The reliable assessment of capillary CAA is of particular importance in Table 7 Type of pathology Here we noted that when only one cortical region was assessed, the agreement rates dropped marginally but more importantly the detection of CAA and particularly capillary CAA did change signiWcantly, declining from 10 to 7 cases. Capillary CAA in one brain region has been assessed by Attems and Jellinger in 2004 [7] and by Jeynes and Provias in 2006 [14] . Both groups reported a signiWcant correlation between capillary CAA and AD lesions. Based on our results, the strong association between AD lesions and capillary CAA should probably be re-evaluated including a larger number of regions. In 2008, Attems and colleagues reported a low prevalence of intracerebral haemorrhage in sporadic CAA when they assessed CAA in frontal and occipital cortices and also hippocampus [8] . While applying their strategy, including these three brain areas in the assessment, all 28 subjects with CAA were identiWed and in nine out of ten cases type 1 CAA was detected by most of the observers. Thus, by assessing these three blocks essentially equivalent results can be achieved as by assessing all ten blocks.
In epidemiological studies, one may need to assess huge sample sizes, e.g. thousands of cases. This is also the case when searching for risk genes. In both situations, material obtained from several laboratories will need to be combined. Furthermore, not only numerous samples need to be evaluated but they also have to be reliably and reproducibly characterized. Here we report that a high agreement can be achieved while assessing the regional distribution of A -IR pathology and the absence/presence of CAA. With respect of capillary CAA, it should be borne in mind that a mild focal capillary CAA might be overlooked whereas in those cases where there is moderate involvement, the agreement regarding the detection of type 1 CAA is rather high. This reliable assessment of A phase, presence/absence of CAA and type 1 CAA was reached by staining a standardized set of blocks taken from six neuroanatomical regions and by applying a commercially available reagent. The investigators were requested to follow written instructions. It is noteworthy that most of the blocks included here are currently routinely sampled by the majority of laboratories and thus even large scale retrospective studies could be organized. Therefore, determination of the phase of A -deposition may represent a reliable and reproducible tool to describe and quantify AD related A pathology in post-mortem brain specimens. In a typical case, the detected immunoreactivity is seen as described in the table. A case that by passes any of the regions is assigned as being atypical and the European Community is not liable for any use that may be made of the information contained therein. The study has been approved by the Ethics Committee of Kuopio University Hospital.
